Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Sep-18 |
3
Dec-18 |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,978 | 9,476 | 8,338 | 10,110 | 12,126 | 11,391 | 10,048 | 14,853 | |
Other income | Rs m | 138 | 126 | 146 | 194 | 143 | 176 | 133 | 117 | |
Turnover | Rs m | 10,116 | 9,602 | 8,484 | 10,304 | 12,269 | 11,567 | 10,181 | 14,969 | |
Expenses | Rs m | 8,250 | 7,159 | 6,591 | 8,160 | 9,510 | 8,736 | 8,121 | 8,973 | |
Gross profit | Rs m | 1,728 | 2,317 | 1,747 | 1,950 | 2,616 | 2,654 | 1,927 | 5,880 | |
Depreciation | Rs m | 432 | 426 | 416 | 420 | 451 | 462 | 454 | 452 | |
Interest | Rs m | 24 | 49 | 63 | 45 | 41 | 38 | 35 | 25 | |
Profit before tax | Rs m | 1,410 | 1,968 | 1,414 | 1,680 | 2,267 | 2,331 | 1,572 | 5,519 | |
Tax | Rs m | 213 | 366 | 319 | 359 | 307 | 365 | 294 | 983 | |
Profit after tax | Rs m | 1,197 | 1,602 | 1,095 | 1,321 | 1,960 | 1,966 | 1,278 | 4,536 | |
Gross profit margin | % | 17.3 | 24.5 | 20.9 | 19.3 | 21.6 | 23.3 | 19.2 | 39.6 | |
Effective tax rate | % | 15.1 | 18.6 | 22.6 | 21.4 | 13.5 | 15.6 | 18.7 | 17.8 | |
Net profit margin | % | 12.0 | 16.9 | 13.1 | 13.1 | 16.2 | 17.3 | 12.7 | 30.5 | |
Diluted EPS | Rs | 9.5 | 12.7 | 8.7 | 10.5 | 15.5 | 15.6 | 10.1 | 35.9 | |
Diluted EPS (TTM) | Rs | 27.1 | 31.4 | 36.0 | 41.3 | 47.4 | 50.3 | 51.7 | 77.2 | |
![]() |
Read: IPCA Labs 1QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: WOCKHARDT SUVEN LIFE SCIENCES ORCHID PHARMA ALEMBIC SUN PHARMA
Compare IPCA LABS With: WOCKHARDT SUVEN LIFE SCIENCES ORCHID PHARMA ALEMBIC SUN PHARMA
Compare IPCA LABS With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More